Cite
MLA Citation
V. Siddagangaiah et al.. “Alemtuzumab induction allows better rejection free graft survival incomparison to basiliximab albeit increased post transplant viralinfections.” International journal of surgery, vol. 36, n.d., pp. S107–. http://access.bl.uk/ark:/81055/vdc_100040046614.0x00004e